NSAIDs: gastroprotection or selective COX-2 inhibitors?

Dickman A , Ellershaw J . NSAIDs: gastroprotection or selective COX-2 inhibitor? Palliat Med 2004; 18: 275–286 .

Barkin RL , Buvanendram A . Focus on the COX-1 and COX-2 agents: renal events of nonsteroidal and antiinflammatory drugs-NSAIDs . Am J Ther 2004; 11: 124–129 .

Kramer BK , Kammerl MC , Komhoff M . Renal cyclooxygenase-2 (COX-2). Physiological, pathophysiological, and clinical implications . Kidney Blood Press Res 2004; 27: 43–62 .

Brater DC . Renal effects of cyclooxygenase-2-selective inhibitors . J Pain Symptom Manage 2002; 23: S15–S20; discussion S21–S23 .

Harris RC , Breyer MD . Physiological regulation of cyclooxygenase-2 in the kidney . Am J Renal Physiol 2001; 281: F1–F11 .

Dai W , Kloner R . Relationship between cyclooxygenase-2 inhibition and thrombogenesis . J Cardiovasc Pharmacol Ther 2004; 9: 51–59 .

Eras J , Perazella MA . NSAIDs and the kidney revisited: are selective cyclooxygenase-2 inhibitors safe? Am J Med Sci 2001; 321: 181–190 .

FitzGerald GA . Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations . Am J Cardiol 2002; 89: 26D–32D .

McCormack K , Twycross R . Are COX-2 selective inhibitors effective analgesics? Pain Rev 2001; 8: 13–26 .

Lunder Y , Sauter S , Fürst C-J . Evidence-based palliative care: beliefs and evidence for changing practice . Palliat Med 2004; 18: 265–266 .